What is the clinical significance of increased serum CYFRA 21-1 and CEA concentrations in the patients with advanced NSCLC?

被引：0
|
作者：
Szturmowicz, M [1 ]
Zaleska, M [1 ]
Zych, J [1 ]
Roszkowska, B [1 ]
Langfort, R [1 ]
Demkow, U [1 ]
Roszkowski-Sliz, K [1 ]
机构：
[1] Natl Inst TB & Lung Dis, Warsaw, Poland
来源：
CHEST | 2004年 / 126卷 / 04期
关键词：
D O I：
10.1378/chest.126.4_MeetingAbstracts.913S-a
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：913S / 913S
页数：1
相关论文
共 50 条
  • [21] Level of SCC, CEA, and CYFRA 21-1 in the serum as an early indicator of treatment efficacy in advanced cervical cancer
    Bartnik, W
    Wojcieszek, A
    Czernik, E
    Deja, R
    CLINICA CHIMICA ACTA, 2005, 355 : S435 - S435
  • [22] Serum tumor marker CYFRA 21-1 in the diagnostics of NSCLC lung cancer
    Pavicevic, R
    Milicic, J
    Bubanovic, G
    Supe, S
    COLLEGIUM ANTROPOLOGICUM, 1998, 22 (02) : 629 - 635
  • [23] The diagnostic value of Cyfra 21-1, CEA, TPS, TPA-M® and NSE in NSCLC
    Golab, T
    Brulinski, K
    Malinowski, E
    Slowinska-Primus, B
    Kucharz, EJ
    Aronsson, AC
    Smiarowski, A
    Braclik, M
    EFIS 2000: 14TH EUROPEAN IMMUNOLOGY MEETING, 2000, : 811 - 814
  • [24] Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma
    Uenishi, Takahiro
    Yamazaki, Osamu
    Yamamoto, Takatsugu
    Hirohashi, Kazuhiro
    Tanaka, Hiromu
    Tanaka, Shogo
    Hai, Seikan
    Ono, Koichi
    Kubo, Shoji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2006, 13 (03): : 239 - 244
  • [25] PROGNOSTIC IMPACT OF SERUM CYFRA 21-1 IN ADVANCED LUNG ADENOCARCINOMA
    Ono, A.
    Takahashi, T.
    Akamatsu, H.
    Taira, T.
    Shukuya, T.
    Kenmotsu, H.
    Naito, T.
    Murakami, H.
    Endo, M.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 430 - 430
  • [26] CYFRA 21-1 serum analysis in patients with esophageal cancer
    Brockmann, JG
    St Nottberg, H
    Glodny, B
    Heinecke, A
    Senninger, NJ
    CLINICAL CANCER RESEARCH, 2000, 6 (11) : 4249 - 4252
  • [27] Prognostic value of a tumor marker index (TMI) based on CYFRA 21-1 and CEA in NSCLC patients treated by surgery
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4802 - 4803
  • [28] Early CYFRA 21-1 variation, response to chemotherapy, and survival, in loccaly advanced NSCLC
    Merle, P
    Janicot, H
    Filaire, M
    Roux, D
    Bailly, C
    Vincent, C
    Tchirkov, A
    Escnde, G
    Caillaud, D
    Verrelle, P
    LUNG CANCER, 2005, 49 : S284 - S284
  • [29] Serum Cyfra 21-1 as a co-variable in future NSCLC chemotherapy trials
    Watine, J
    LUNG CANCER, 2001, 33 (01) : 89 - 91
  • [30] CLINICAL UTILITY OF SERUM CYFRA 21-1 IN PATIENT WITH THYMIC CARCINOMA
    Tateishi, Kazunari
    Koizumi, Tomonobu
    Agatsuma, T.
    Sonehara, K.
    Ikeda, M.
    Kinoda, F.
    Ichiyama, T.
    Hama, M.
    Ikegami, K.
    Tokoro, Y.
    Kobayashi, N.
    Horiuchi, M.
    Yokoyama, T.
    Ushiki, A.
    Kobayashi, T.
    Yasuo, M.
    Urushihata, K.
    Yamamoto, H.
    Hanaoka, M.
    Kubo, K.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S419 - S419
12345